Navigation Links
Nomad Bioscience Announces Broad License Agreement
Date:9/29/2008

MUNICH, Germany, Sept. 29 /PRNewswire/ -- Nomad Bioscience GmbH announces that it entered into a broad licensing agreement with Bayer Innovation GmbH and Icon Genetics group. It provides Nomad access to Icon's proprietary technology platforms, including its transient expression technology magnICON(R), for manufacturing biomaterials and selected biosimilar pharmaceutical proteins in green plants. The agreement provides Nomad with a strategically needed freedom to operate in its core business areas. The financial terms of the agreement are not disclosed.

"Icon Genetics' proprietary gene transfer systems provide a broad solution to the upstream part of manufacturing, and combined with Nomad downstream technologies, they should result in a superior fully integrated process for most of our intended product candidates," said Dr. Yuri Gleba, the founder of Nomad Bioscience. Prof. Dr. Gleba is also co-inventor of Icon's technologies as well as co-founder and managing director of Icon Genetics.

"Icon has developed new generation production platforms that are by far more effective than those commercialized today. Since our own strategic focus is on proprietary biopharmaceuticals, we were looking for a partner who could best apply our proprietary expression methods to other new classes of products," said Dr. Detlef Wollweber, Managing Director of Bayer Innovation.

About Nomad Bioscience:

Nomad Bioscience, headquartered in Munich, is a private start-up biotechnology company developing a series of high value materials such as nanopatterned materials, protein scaffolds, proteins and enzymes for important markets including biosimilar biopharmaceuticals, electric batteries and biofuels.


'/>"/>
SOURCE Nomad Bioscience GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LI-COR Biosciences Offers $1.75 Million in Matching Funds for Undergraduate Genomics Education
2. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
3. Tethys Bioscience Announces Acquisition of Lipomics Technologies
4. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
5. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
6. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
7. Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting
8. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
9. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
10. Protect Marylands Bioscience Industry
11. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published in ... and fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched ... , After comparing the results from the fresh and frozen transfer cohorts, the ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):